134 related articles for article (PubMed ID: 6093598)
1. Effects of palmitoyl carnitine and LPC on cardiac sarcolemmal Na+-K+-ATPase.
Pitts BJ; Okhuysen CH
Am J Physiol; 1984 Nov; 247(5 Pt 2):H840-6. PubMed ID: 6093598
[TBL] [Abstract][Full Text] [Related]
2. Effect of palmitoyl carnitine on Na+, K+-ATPase and adenylate cyclase activity of canine myocardial sarcolemma.
Abe M; Yamazaki N; Suzuki Y; Kobayashi A; Ohta H
J Mol Cell Cardiol; 1984 Mar; 16(3):239-45. PubMed ID: 6325716
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of sarcolemmal Na+-K+-ATPase by palmitoyl carnitine: potentiation by propranolol.
Kramer JH; Weglicki WB
Am J Physiol; 1985 Jan; 248(1 Pt 2):H75-81. PubMed ID: 2982278
[TBL] [Abstract][Full Text] [Related]
4. Effects of fatty acid intermediates on Na+-K+-ATPase activity of cardiac sarcolemma.
Owens K; Kennett FF; Weglicki WB
Am J Physiol; 1982 Mar; 242(3):H456-61. PubMed ID: 6278956
[TBL] [Abstract][Full Text] [Related]
5. The effect of lipid intermediates on Ca2+ and Na+ permeability and (Na+ + K+)-ATPase of cardiac sarcolemma. A possible role in myocardial ischemia.
Lamers JM; Stinis HT; Montfoort A; Hülsmann WC
Biochim Biophys Acta; 1984 Jul; 774(1):127-37. PubMed ID: 6329291
[TBL] [Abstract][Full Text] [Related]
6. Interaction of palmitoyl carnitine with calcium antagonists in myocytes.
Patmore L; Duncan GP; Spedding M
Br J Pharmacol; 1989 Jun; 97(2):443-50. PubMed ID: 2474346
[TBL] [Abstract][Full Text] [Related]
7. Effects of some L-carnitine derivatives on heart membrane ATPases.
Dhalla NS; Kolár F; Shah KR; Ferrari R
Cardiovasc Drugs Ther; 1991 Feb; 5 Suppl 1():25-30. PubMed ID: 1851632
[TBL] [Abstract][Full Text] [Related]
8. Lysophosphatidylcholine increases cytosolic calcium in ventricular myocytes by direct action on the sarcolemma.
Woodley SL; Ikenouchi H; Barry WH
J Mol Cell Cardiol; 1991 Jun; 23(6):671-80. PubMed ID: 1658342
[TBL] [Abstract][Full Text] [Related]
9. The inhibition of Na+ and K+ stimulated ATPase activity of rabbit and dog heart sarcolemma by lysophosphatidyl choline.
Karli JN; Karikas GA; Hatzipavlou PK; Levis GM; Moulopoulos SN
Life Sci; 1979 May; 24(20):1869-75. PubMed ID: 222984
[No Abstract] [Full Text] [Related]
10. Phosphorylation of cardiac Na+-K+ ATPase by Ca2+/calmodulin dependent protein kinase.
Netticadan T; Kato K; Tappia P; Elimban V; Dhalla NS
Biochem Biophys Res Commun; 1997 Sep; 238(2):544-8. PubMed ID: 9299548
[TBL] [Abstract][Full Text] [Related]
11. Sarcolemmal Na+-K+-ATPase activity in diabetic rat heart.
Pierce GN; Dhalla NS
Am J Physiol; 1983 Sep; 245(3):C241-7. PubMed ID: 6137147
[TBL] [Abstract][Full Text] [Related]
12. Potentiation of free radical-induced lipid peroxidative injury to sarcolemmal membranes by lipid amphiphiles.
Mak IT; Kramer JH; Weglicki WB
J Biol Chem; 1986 Jan; 261(3):1153-7. PubMed ID: 3003057
[TBL] [Abstract][Full Text] [Related]
13. Influence of calcium antagonists on heart sarcolemmal (Na+ + K(+)-ATPase.
Dzurba A; Breier A; Slezák J; Stankovicová T; Vrbjar N; Ziegelhöffer A
Bratisl Lek Listy; 1991; 92(3-4):155-8. PubMed ID: 1851463
[TBL] [Abstract][Full Text] [Related]
14. Singlet oxygen-induced inhibition of cardiac sarcolemmal Na+K(+)-ATPase.
Vinnikova AK; Kukreja RC; Hess ML
J Mol Cell Cardiol; 1992 May; 24(5):465-70. PubMed ID: 1321912
[TBL] [Abstract][Full Text] [Related]
15. Effect of heparin on myocardial contractility of the dog and on Na, K-ATPase.
Karli J; Stamatelopoulos S; Karikas G; Levis G; Moulopoulos S
Res Commun Chem Pathol Pharmacol; 1984 Jan; 43(1):79-96. PubMed ID: 6142512
[TBL] [Abstract][Full Text] [Related]
16. Effects of adenosine on transmembrane potential and sarcolemmal Na+-K+ ATPase activity of human atrial myocardium.
Lee YS; Chang CH
Jpn Heart J; 1985 Jan; 26(1):69-80. PubMed ID: 2989573
[TBL] [Abstract][Full Text] [Related]
17. Unmasking effect of alamethicin on the (Na+,K+)-ATPase, beta-adrenergic receptor-coupled adenylate cyclase, and cAMP-dependent protein kinase activities of cardiac sarcolemmal vesicles.
Jones LR; Maddock SW; Besch HR
J Biol Chem; 1980 Oct; 255(20):9971-80. PubMed ID: 6253461
[TBL] [Abstract][Full Text] [Related]
18. In vitro effects of palmitylcarnitine on cardiac plasma membrane Na,K-ATPase, and sarcoplasmic reticulum Ca2+-ATPase and Ca2+ transport.
Adams RJ; Cohen DW; Gupte S; Johnson JD; Wallick ET; Wang T; Schwartz A
J Biol Chem; 1979 Dec; 254(24):12404-10. PubMed ID: 227894
[No Abstract] [Full Text] [Related]
19. Features of the (Na, K)-ATPase of cardiac sarcolemma with particular reference to myocardial ischaemia.
Vrbjar N; Slezak J; Ziegelhoffer A; Tribulova N
Eur Heart J; 1991 Dec; 12 Suppl F():149-52. PubMed ID: 1666553
[TBL] [Abstract][Full Text] [Related]
20. Selective and reversible inhibition of heart sarcolemmal (Na+ + K+)-ATPase by p-bromophenyl isothiocyanate. Evidence for a sulfhydryl group in the ATP-binding site of the enzyme.
Ziegelhöffer A; Breier A; Dzurba A; Vrbjar N
Gen Physiol Biophys; 1983 Dec; 2(6):447-56. PubMed ID: 6088362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
